A conversation with Azul Bio Synopsis: Back to Blue’s lead editor, Naka Kondo speaks to Ben Alva, the founder of Azul Bio, a startup developing microbiome-based treatments and probiotics from nature that give ocean life immunity to human impact, such as coral resilience. They are planning their first pilot in November.
From robots and AI modelling tools to nature-based innovations, startups and academic research teams are helping monitor changes to the ocean and restore this vital ecosystem to its optimal state.
videos
Duration: 2mins
Duration: 9mins
Duration: 8.5mins
Back to Blue explores evidence-based approaches and solutions to the pressing issues faced by the ocean, to restoring ocean health and promoting sustainability. Sign up to our monthly Back to Blue newsletter to keep updated with the latest news, research and events from Back to Blue and Economist Impact.
The Economist Group is a global organisation and operates a strict privacy policy around the world.
Please see our privacy policy here.
Thank you for your interest in Back to Blue, please feel free to explore our content.
If you would like to co-design the Back to Blue roadmap or have feedback on content, events, editorial or media-related feedback, please fill out the form below. Thank you.
The Economist Group is a global organisation and operates a strict privacy policy around the world.
Please see our privacy policy here.
Continue reading by downloading the full report: THE INVISIBLE WAVE: GETTING TO ZERO CHEMICAL POLLUTION IN THE OCEAN
The scourge of untreated wastewater
Slowing
the chemical tide: safeguarding human and ocean health amid
chemical pollution
Hazardous chemicals in plastics - the discussions at INC
